The Chinese healthcare and life sciences industry is fast-growing but highly regulated, and therefore international players require the support of lawyers who understand and are able to navigate the constantly evolving economic and regulatory landscapes in China. R&P provides legal and business solutions from China market entry to the actual marketing and sales of products in China. As a long-term partner, we make it a priority to understand our client’s goals, commit to provisional timelines and ensure that clients are able to respond to rapid changes in the market.
Our regulatory team supports international companies in biotechnology, medical devices, pharmaceuticals, healthcare services, cosmetics and foodstuffs. Focus areas include CNDA approval and recordings, regulatory opinions, product compliance and labeling, responding to regulatory investigations, consumer claims, unfair competition and anti-bribery. We also regularly support clients on corporate structuring, joint ventures and M&A.
